AYA WERRA: Open Payments
NPI 1093340770 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 100 payments from 14 companies in 2025. Trend: 2023 $2,771 · 2024 $2,356 · 2025 $2,156
Food & beverage: $2,124Consulting: $30Education: $2
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 39 | $915 |
| ABBVIE INC. | 10 | $241 |
| Merck Sharp & Dohme LLC | 7 | $201 |
| Gilead Sciences, Inc. | 14 | $189 |
| Shionogi Inc | 10 | $177 |
| Paratek Pharmaceuticals, Inc. | 6 | $109 |
| La Jolla Pharmaceutical Company | 3 | $60 |
| Ferring Pharmaceuticals Inc. | 2 | $58 |
| Melinta Therapeutics, LLC | 2 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
Products named: CABENUVA, Fetroja, APRETUDE, DOVATO, PIFELTRO, NUZYRA, AVYCAZ, DALVANCE.
Industry payments across NV — which companies pay providers there.
